Spots Global Cancer Trial Database for Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors
Official Title: Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Safety And Efficacy Of 2 Doses Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate With Inadequate Response To TNF Inhibitors
Study ID: NCT00960440
Conditions
Study Description
Brief Summary: This study will test if CP-690,550 is safe and effective in rheumatoid arthritis patients taking methotrexate who have an inadequate response to tumor necrosis factor inhibitor treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Birmingham, Alabama, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, San Diego, California, United States
Pfizer Investigational Site, Farmington, Connecticut, United States
Pfizer Investigational Site, Trumbull, Connecticut, United States
Pfizer Investigational Site, Aventura, Florida, United States
Pfizer Investigational Site, Tampa, Florida, United States
Pfizer Investigational Site, Atlanta, Georgia, United States
Pfizer Investigational Site, Boise, Idaho, United States
Pfizer Investigational Site, Idaho Falls, Idaho, United States
Pfizer Investigational Site, Springfield, Illinois, United States
Pfizer Investigational Site, Indianapolis, Indiana, United States
Pfizer Investigational Site, New Orleans, Louisiana, United States
Pfizer Investigational Site, Portland, Maine, United States
Pfizer Investigational Site, Cumberland, Maryland, United States
Pfizer Investigational Site, Worcester, Massachusetts, United States
Pfizer Investigational Site, Flowood, Mississippi, United States
Pfizer Investigational Site, Tupelo, Mississippi, United States
Pfizer Investigational Site, Lebanon, New Hampshire, United States
Pfizer Investigational Site, Voorhees, New Jersey, United States
Pfizer Investigational Site, Rocky Mount, North Carolina, United States
Pfizer Investigational Site, Bethlehem, Pennsylvania, United States
Pfizer Investigational Site, Willow Grove, Pennsylvania, United States
Pfizer Investigational Site, Wyomissing, Pennsylvania, United States
Pfizer Investigational Site, Hixson, Tennessee, United States
Pfizer Investigational Site, Knoxville, Tennessee, United States
Pfizer Investigational Site, Nashville, Tennessee, United States
Pfizer Investigational Site, Dallas, Texas, United States
Pfizer Investigational Site, Dallas, Texas, United States
Pfizer Investigational Site, Fort Worth, Texas, United States
Pfizer Investigational Site, Houston, Texas, United States
Pfizer Investigational Site, Lubbock, Texas, United States
Pfizer Investigational Site, Vancouver, Washington, United States
Pfizer Investigational Site, Vancouver, Washington, United States
Pfizer Investigational Site, Vancouver, Washington, United States
Pfizer Investigational Site, Kogarah, New South Wales, Australia
Pfizer Investigational Site, Daw Park, South Australia, Australia
Pfizer Investigational Site, Heidelberg, Victoria, Australia
Pfizer Investigational Site, Wien, , Austria
Pfizer Investigational Site, Wien, , Austria
Pfizer Investigational Site, Wien, , Austria
Pfizer Investigational Site, Wien, , Austria
Pfizer Investigational Site, Genk, , Belgium
Pfizer Investigational Site, Hasselt, , Belgium
Pfizer Investigational Site, Kortrijk, , Belgium
Pfizer Investigational Site, Liège, , Belgium
Pfizer Investigational Site, Goiania, GO, Brazil
Pfizer Investigational Site, Curitiba, PR, Brazil
Pfizer Investigational Site, Porto Alegre, RS, Brazil
Pfizer Investigational Site, Sao Paulo, SP, Brazil
Pfizer Investigational Site, Winnipeg, Manitoba, Canada
Pfizer Investigational Site, Hamilton, Ontario, Canada
Pfizer Investigational Site, Hamilton, Ontario, Canada
Pfizer Investigational Site, Ottawa, Ontario, Canada
Pfizer Investigational Site, Montreal, Quebec, Canada
Pfizer Investigational Site, Pointe Claire, Quebec, Canada
Pfizer Investigational Site, Amiens, , France
Pfizer Investigational Site, Lyon, , France
Pfizer Investigational Site, Orleans Cedex 1, , France
Pfizer Investigational Site, Orleans, , France
Pfizer Investigational Site, Paris, , France
Pfizer Investigational Site, Paris, , France
Pfizer Investigational Site, Berlin, , Germany
Pfizer Investigational Site, Berlin, , Germany
Pfizer Investigational Site, Erlangen, , Germany
Pfizer Investigational Site, Frankfurt am Main, , Germany
Pfizer Investigational Site, Halle, , Germany
Pfizer Investigational Site, Hamburg, , Germany
Pfizer Investigational Site, Koeln, , Germany
Pfizer Investigational Site, Leipzig, , Germany
Pfizer Investigational Site, Rheine, , Germany
Pfizer Investigational Site, Wuerzburg, , Germany
Pfizer Investigational Site, Croom, Co. Limerick, Ireland
Pfizer Investigational Site, Dublin, , Ireland
Pfizer Investigational Site, Firenze, , Italy
Pfizer Investigational Site, Jesi, , Italy
Pfizer Investigational Site, Busan, , Korea, Republic of
Pfizer Investigational Site, Daegu, , Korea, Republic of
Pfizer Investigational Site, Seoul, , Korea, Republic of
Pfizer Investigational Site, San Juan, , Puerto Rico
Pfizer Investigational Site, Santiago de Compostela, A Coruña, Spain
Pfizer Investigational Site, Merida, Badajoz, Spain
Pfizer Investigational Site, Bilbao, Bizkaia, Spain
Pfizer Investigational Site, Santander, Cantabria, Spain
Pfizer Investigational Site, Baracaldo, Vizcaya, Spain
Pfizer Investigational Site, Madrid, , Spain
Pfizer Investigational Site, Valencia, , Spain
Pfizer Investigational Site, Niao Sung Hsiang, Kaohsiung County, Taiwan
Pfizer Investigational Site, Kweishan, Taoyuan County, Taiwan
Pfizer Investigational Site, Changhua, , Taiwan
Pfizer Investigational Site, Kaohsiung, , Taiwan
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
